Literature DB >> 10637601

Multiple physiological functions for multidrug transporter P-glycoprotein?

R W Johnstone1, A A Ruefli, M J Smyth.   

Abstract

Multidrug resistance mediated by the drug-efflux protein P-glycoprotein (P-gp) is one mechanism that tumor cells use to escape death induced by chemotherapeutic drugs. Although it is irrefutable that P-gp can efflux xenobiotics out of cells, biological regulatory functions for P-gp in multicellular organisms have yet to be established firmly. Recent observations have challenged the notion that P-gp has evolved merely to efflux xenotoxins out of healthy cells and raised the possibility that P-gp and related transporter molecules might play a fundamental role in regulating cell differentiation, proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10637601     DOI: 10.1016/s0968-0004(99)01493-0

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  66 in total

1.  The E23 early gene of Drosophila encodes an ecdysone-inducible ATP-binding cassette transporter capable of repressing ecdysone-mediated gene activation.

Authors:  T Hock; T Cottrill; J Keegan; D Garza
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study.

Authors:  T H Tsai; S C Liu; P L Tsai; L K Ho; A Y C Shum; C F Chen
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Mechanisms of apoptosis are retained in cells with P glycoprotein-mediated drug resistance.

Authors:  A G Paleeva; G E Onishchenko; A A Shtil
Journal:  Dokl Biol Sci       Date:  2006 Mar-Apr

4.  Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients.

Authors:  Minghua Ji; Jinhai Tang; Jianhua Zhao; Bin Xu; Jianwei Qin; Jianwei Lu
Journal:  Cancer Biol Ther       Date:  2012-03-01       Impact factor: 4.742

5.  MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case-control studies.

Authors:  Xiaojing Sheng; Limei Zhang; Na Tong; Dewei Luo; Meilin Wang; Min Xu; Zhengdong Zhang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

6.  Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel.

Authors:  Ravi S Kasinathan; William M Morgan; Robert M Greenberg
Journal:  Mol Biochem Parasitol       Date:  2010-05-12       Impact factor: 1.759

7.  Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.

Authors:  Soichi Haraguchi; Sarah K Ho; Matthew Morrow; Maureen M Goodenow; John W Sleasman
Journal:  J Leukoc Biol       Date:  2011-04-19       Impact factor: 4.962

8.  MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling.

Authors:  Toshiyuki Sakaeda; Tsutomu Nakamura; Midori Hirai; Takashi Kimura; Atsushi Wada; Tatsurou Yagami; Hironao Kobayashi; Shunji Nagata; Noboru Okamura; Takayoshi Yoshikawa; Toshiro Shirakawa; Akinobu Gotoh; Masafumi Matsuo; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

9.  Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

Authors:  Vibeke Andersen; Mette Ostergaard; Jane Christensen; Kim Overvad; Anne Tjønneland; Ulla Vogel
Journal:  BMC Cancer       Date:  2009-11-21       Impact factor: 4.430

10.  The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer.

Authors:  Wen-Qing Hu; Chun-Wei Peng; Yan Li
Journal:  J Exp Clin Cancer Res       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.